HEPA
Closed
Hepion Pharmaceuticals Inc
0.0681
-0.0119 (-14.88%)
Last Update: 01 Jul 2025 22:59:00
Yesterday: 0.08
Day's Range: 0.058 - 0.0723
Send
sign up or login to leave a comment!
When Written:
0.75
Hepion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of drugs to treat liver disease. The company's lead drug candidate, CRV431, is a cyclophilin inhibitor that has shown potential in preclinical studies to treat a range of liver diseases, including non-alcoholic steatohepatitis (NASH), viral hepatitis, and liver fibrosis. Hepion is also developing additional drug candidates targeting liver diseases, including a combination therapy for NASH. The company is headquartered in Edison, New Jersey and was founded in 2013.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








